Gary Hunter
Overview
Explore the profile of Gary Hunter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
486
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sujanthan S, Puveendrakumaran P, Dainty K, Barense M, Lanctot K, Owen A, et al.
Eur Stroke J
. 2025 Mar;
:23969873251323171.
PMID: 40071564
Introduction: Post-stroke cognitive impairment is associated with impaired quality of life. Remote testing provides a potential avenue to measure cognitive outcomes efficiently. Patients And Methods: Prospective cognitive outcomes were collected...
2.
Siddiqi A, Ignacio K, Kaveeta C, Bala F, Ademola A, Tkach A, et al.
J Stroke
. 2025 Feb;
27(1):113-117.
PMID: 39916460
No abstract available.
3.
Siddiqi A, Ignacio K, Kaveeta C, Bala F, Ademola A, Tkach A, et al.
J Am Heart Assoc
. 2024 Dec;
14(1):e037577.
PMID: 39704225
Background: About 25% of patients with acute ischemic stroke have lacunar infarct on follow-up imaging. In this secondary analysis from the AcT (Alteplase Compared With Tenecteplase) trial, we assessed if...
4.
Charatpangoon P, Singh N, Buck B, Carpani F, Catanese L, Coutts S, et al.
Can J Neurol Sci
. 2024 Dec;
:1-10.
PMID: 39632722
Background: Clinical trials often struggle to recruit enough participants, with only 10% of eligible patients enrolling. This is concerning for conditions like stroke, where timely decision-making is crucial. Frontline clinicians...
5.
Bala F, Diprose W, Menon B, Singh N, Khosravani H, Tkach A, et al.
J Neurointerv Surg
. 2024 Oct;
PMID: 39379314
Background: Intravenous (IV) tenecteplase is increasingly being used in lieu of alteplase for acute ischemic stroke. We sought to study the influence of IV tenecteplase versus IV alteplase on the...
6.
Cimflova P, Alhabli I, Bala F, Horn M, Benali F, Buck B, et al.
J Stroke Cerebrovasc Dis
. 2024 Sep;
33(11):107985.
PMID: 39222700
Objectives: There are limited data available demonstrating the safety and efficacy of intravenous tenecteplase versus alteplase in patients with acute ischemic stroke in the posterior circulation. Materials And Methods: This...
7.
Kaveeta C, Alhabli I, Bala F, Horn M, Benali F, Coutts S, et al.
Int J Stroke
. 2024 Aug;
20(1):64-74.
PMID: 39086232
Background: Early ischemic changes on baseline imaging are commonly evaluated for acute stroke decision-making and prognostication. Aims: We assess the association of early ischemic changes on clinical outcomes and whether...
8.
Bala F, Singh N, Ignacio K, Alhabli I, Ademola A, Alrohimi A, et al.
J Stroke
. 2024 Jun;
26(2):280-289.
PMID: 38836275
Background And Purpose: The safety and efficacy of tenecteplase in patients with ischemic stroke due to medium vessel occlusion (MeVO) are not well studied. We aimed to compare tenecteplase with...
9.
Coutts S, Ankolekar S, Appireddy R, Arenillas J, Assis Z, Bailey P, et al.
Lancet
. 2024 May;
403(10444):2597-2605.
PMID: 38768626
Background: Individuals with minor ischaemic stroke and intracranial occlusion are at increased risk of poor outcomes. Intravenous thrombolysis with tenecteplase might improve outcomes in this population. We aimed to test...
10.
Little R, Carter S, Motl R, Hunter G, Cook A, Liu N, et al.
BMJ Open
. 2024 May;
14(5):e081660.
PMID: 38702085
Introduction: Breast cancer survivors have an increased risk for chronic fatigue and altered gut microbiota composition, both with negative health and quality of life affects. Exercise modestly improves fatigue and...